You are here

Cancer Innovations

Morphotek(R), Inc. and Cancer Innovations, Inc. Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies

PR NewsWire

Wed, 07/15/09 - 10:42 am

Cancer Innovations